What features could Amgen add to its Repatha autoinjector to make it more user-friendly for patients with arthritis?

Introduction

To improve Amgen's Repatha autoinjector for patients with arthritis, we need to focus on enhancing its user-friendliness. This challenge requires a deep understanding of the unique needs of arthritis patients and how we can adapt the autoinjector to better serve them. I'll approach this by examining user segments, analyzing pain points, generating solutions, and prioritizing improvements.

Step 1

Clarifying Questions

• Looking at the product context, I'm thinking about the specific challenges arthritis patients face when using autoinjectors. Could you provide more details on the current design of the Repatha autoinjector and any existing features aimed at improving usability for patients with limited dexterity?

Why it matters: Understanding the current design will help identify gaps and improvement opportunities. Expected answer: The autoinjector has a cylindrical shape with a button-activated mechanism. Impact on approach: Would focus on ergonomic improvements and alternative activation methods.

• Considering user behavior, I'm curious about the frequency of Repatha injections and the typical environment where patients use the autoinjector. Can you share insights on the dosing schedule and whether patients usually self-administer at home or in clinical settings?

Why it matters: Frequency and setting influence the design priorities for convenience and ease of use. Expected answer: Bi-weekly or monthly injections, primarily self-administered at home. Impact on approach: Would emphasize features that support regular, independent use in a home environment.

• Thinking about pain points and market position, how does the current Repatha autoinjector compare to competitors in terms of usability for arthritis patients? Are there specific areas where users have reported difficulties or preferences?

Why it matters: Identifies competitive advantages and areas for differentiation. Expected answer: Some difficulties reported with grip and activation force required. Impact on approach: Would prioritize innovations in grip design and force reduction mechanisms.

• Regarding product lifecycle and company alignment, where is Repatha in its lifecycle, and what are Amgen's key objectives for this product improvement initiative?

Why it matters: Aligns product improvements with broader company goals and market strategy. Expected answer: Mature product seeking to expand market share and improve patient adherence. Impact on approach: Would focus on features that enhance user experience and differentiate from competitors.